Month: March 2025

Reducing Time and Costs in Car-T Development with Precision-Engineered Cell Mimics

The race to bring new drugs and cell therapies like CAR-T to market is more intense than ever. Patients are waiting, and developers face mounting pressure to accelerate timelines, reduce costs, and meet evolving regulatory demands—all without compromising quality. Unfortunately, commonly used controls like engineered cell lines or donor-derived blood cells introduce variability and operational […]

Written by on March 16, 2025

Reproducibility Crisis, Meet Cell Mimics – A Timely Solution to a Persistent Challenge

Every day, new ideas and innovations bring us closer to breakthroughs in how we diagnose, treat, and potentially cure diseases. Reproducibility, or the ability to replicate a scientific study and get results consistent with previous findings, is fundamental to advancing scientific research. Without reproducibility, scientists can’t verify conclusions, detect errors, or build on what’s already […]

Written by on March 13, 2025